Design, methods, and population for a study of PFOA health effects among highly exposed Mid-Ohio Valley community residents and workers

Environmental Health Perspectives

Volumn 121, Issue 8, 2013, Pages 893-899

  Winquist, Andrea ^a   Lally, Cathy ^a   Shin, Hyeong Moo ^b   Steenland, Kyle ^a  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

C8 Science Panel; Cohort study; Perfluorooctanoic acid; PFOA; Study design

Indexed keywords

PERFLUOROOCTANOIC ACID;

ADULT; ARTICLE; CHRONIC DISEASE; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; INTERVIEW; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RESIDENT; RHEUMATOID ARTHRITIS; SENSITIVITY ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CAPRYLATES; CHRONIC DISEASE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; FEMALE; FLUOROCARBONS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; OHIO; PREVALENCE; PROSPECTIVE STUDIES; WATER POLLUTANTS, CHEMICAL; WEST VIRGINIA; YOUNG ADULT;

EID: 84881002727     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1206450     Document Type: Article

References (28)

1. Agency for Toxic Substances and Disease Registry. 2008. Perfluorochemical Contamination in Lake Elmo and Oakdale, Washington County, Minnesota. Available: http://www.health.state.mn.us/divs/eh/hazardous/sites/washington/lakeelmo/phaelmooakdale.pdf [accessed 27 February 2013].
2. Bartell SM, Calafat AM, Lyu C, Kato K, Ryan PB, Steenland K. 2010. Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia. Environ Health Perspect 118:222-228.
3. Brede E, Wilhelm M, Goen T, Muller J, Rauchfuss K, Kraft M, et al. 2010. Twoyear followup biomonitoring pilot study of residents' and controls' PFC plasma levels after PFOA reduction in public water system in Arnsberg, Germany. Int J Hyg Environ Health 213(3):217-223.
4. C8 Science Panel. 2012. C8 Science Panel: C8 Probable Link Reports. Available: http://www.c8sciencepanel.org/prob_link.html [accessed 6 March 2013].
5. Calafat AM, Wong LY, Kuklenyik Z, Reidy JA, Needham LL. 2007. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect 115:1596-1602.
6. Centers for Disease Control and Prevention. 2012. National Death Index. Available: http://www.cdc.gov/nchs/ndi.htm [accessed 17 August 2012].
7. Costa G, Sartori S, Consonni D. 2009. Thirty years of medical surveillance in perfluorooctanoic acid production workers. J Occup Environ Med 51(3):364-372.
8. Emmett EA, Shofer FS, Zhang H, Freeman D, Desai C, Shaw LM. 2006. Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. J Occup Environ Med 48(8):759-770.
9. Eriksen KT, Sorensen M, McLaughlin JK, Lipworth L, Tjonneland A, Overvad K, et al. 2009. Perfluorooctanoate and perfluorooctanesulfonate plasma levels and risk of cancer in the general Danish population. J Natl Cancer Inst 101(8):605-609.
10. Frisbee SJ, Brooks AP Jr, Maher A, Flensborg P, Arnold S, Fletcher T, et al. 2009. The C8 Health Project: design, methods, and participants. Environ Health Perspect 117:1873-1882.
11. Fromme H, Tittlemier SA, Volkel W, Wilhelm M, Twardella D. 2009. Perfluorinated compounds-exposure assessment for the general population in Western countries. Int J Hyg Environ Health 212(3):239-270.
12. Kennedy GL Jr, Butenhoff JL, Olsen GW, O'Connor JC, Seacat AM, Perkins RG, et al. 2004. The toxicology of perfluorooctanoate. Crit Rev Toxicol 34(4):351-384.
13. Lau C, Anitole K, Hodes C, Lai D, PfahlesHutchens A, Seed J. 2007. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99(2):366-394.
14. Leonard RC, Kreckmann KH, Sakr CJ, Symons JM. 2008. Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers. Ann Epidemiol 18(1):15-22.
15. Lundin JI, Alexander BH, Olsen GW, Church TR. 2009. Ammonium perfluorooctanoate production and occupational mortality. Epidemiology 20(6):921-928.
16. Olsen GW, Burris JM, Burlew MM, Mandel JH. 2003. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J Occup Environ Med 45(3):260-270.
17. Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL, et al. 2007. Halflife of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 115:1298-1305.
18. Paustenbach DJ, Panko JM, Scott PK, Unice KM. 2007. A methodology for estimating human exposure to perfluorooctanoic acid (PFOA): a retrospective exposure assessment of a community (1951-2003). J Toxicol Environ Health A 70:28-57.
19. Prevedouros K, Cousins IT, Buck RC, Korzeniowski SH. 2006. Sources, fate and transport of perfluorocarboxylates. Environ Sci Technol 40(1):32-44.
20. Sakr CJ, Leonard RC, Kreckmann KH, Slade MD, Cullen MR. 2007. Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate. J Occup Environ Med 49(8):872-879.
21. Shin HM, Ryan PB, Vieira VM, Bartell SM. 2012. Modeling the air-soil transport pathway of perfluorooctanoic acid in the midOhio Valley using linked air dispersion and vadose zone models. Atmos Environ 51:67-74.
22. Shin HM, Vieira VM, Ryan PB, Detwiler R, Sanders B, Steenland K, et al. 2011a. Environmental fate and transport modeling for perfluorooctanoic acid emitted from the Washington Works facility in West Virginia. Environ Sci Technol 45:1435-1442.
23. Shin HM, Vieira VM, Ryan PB, Steenland K, Bartell SM. 2011b. Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health Project. Environ Health Perspect 119:1760-1765.
24. Steenland K, Fletcher T, Savitz DA. 2010. Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ Health Perspect 118:1100-1108.
25. Steenland K, Jin C, MacNeil J, Lally C, Ducatman A, Vieira V, et al. 2009. Predictors of PFOA levels in a community surrounding a chemical plant. Environ Health Perspect 117:1083-1088.
26. Strynar MJ, Lindstrom AB. 2008. Perfluorinated compounds in house dust from Ohio and North Carolina, USA. Environ Sci Technol 42:3751-3756.
27. U.S. Renal Data System. 2012. United States Renal Data System. Available: http://www.usrds.org/default.aspx [accessed 17 December 2012].
28. Woskie SR, Gore R, Steenland K. 2012. Retrospective exposure assessment of perfluorooctanoic acid serum concentrations at a fluoropolymer manufacturing plant. Ann Occup Hyg 56(9):1025-1037.